Primaquine pharmacokinetics in lactating women and breastfed infant exposures
Primaquine is the only drug providing radical cure of Plasmodium vivax malaria. It is not recommended for breastfeeding women as it causes hemolysis in glucose-6-phosphate dehydrogenase (G6PD) deficient individuals, and breast milk excretion and thus infant exposure are not known.Healthy G6PD normal...
Главные авторы: | Gilder, M, Hanpithakphong, W, Hoglund, R, Tarning, J, Win, H, Hilda, N, Chu, C, Bancone, G, Carrara, V, Singhasivanon, P, White, N, Nosten, F, McGready, R |
---|---|
Формат: | Journal article |
Язык: | English |
Опубликовано: |
Oxford University Press
2018
|
Схожие документы
-
Population pharmacokinetic modelling of primaquine exposures in lactating women and breastfed infants
по: Wattanakul, T, и др.
Опубликовано: (2024) -
Population pharmacokinetic modelling of primaquine exposures in lactating women and breastfed infants
по: Thanaporn Wattanakul, и др.
Опубликовано: (2024-05-01) -
Mechanistic modeling of primaquine pharmacokinetics, gametocytocidal activity, and mosquito infectivity
по: Chotsiri, P, и др.
Опубликовано: (2022) -
Pharmacokinetic interactions between primaquine and chloroquine.
по: Pukrittayakamee, S, и др.
Опубликовано: (2014) -
Antimalarial drugs for treating and preventing malaria in pregnant and lactating women
по: Saito, M, и др.
Опубликовано: (2018)